

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.15929795 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.15929795 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.83682113 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.83682113 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.40223568 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.12332435 |
| 7 | protein-lipid complex assembly (GO:0065005) | 6.03462904 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.81216246 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.75456950 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.75456950 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.75456950 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.74398811 |
| 13 | intestinal cholesterol absorption (GO:0030299) | 5.72274501 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.68795466 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.56816948 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.40768127 |
| 17 | plasma lipoprotein particle organization (GO:0071827) | 5.35530497 |
| 18 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.29910820 |
| 19 | urea cycle (GO:0000050) | 5.28256368 |
| 20 | urea metabolic process (GO:0019627) | 5.28256368 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.23381152 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.23210274 |
| 23 | cysteine metabolic process (GO:0006534) | 5.19182891 |
| 24 | protein-lipid complex subunit organization (GO:0071825) | 5.05818608 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.05501600 |
| 26 | regulation of plasminogen activation (GO:0010755) | 5.04228909 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.99788083 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96497517 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.94812270 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.93837774 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93438361 |
| 32 | protein carboxylation (GO:0018214) | 4.93438361 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.86388837 |
| 34 | bile acid metabolic process (GO:0008206) | 4.85769595 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.84776961 |
| 36 | lysine metabolic process (GO:0006553) | 4.79038574 |
| 37 | lysine catabolic process (GO:0006554) | 4.79038574 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.73946521 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.71872502 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.63198001 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.62315173 |
| 42 | regulation of complement activation (GO:0030449) | 4.59166238 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.56767009 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54869465 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.54869465 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.54869465 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.53491286 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.50839969 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.50839969 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.48561052 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.46435398 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.42470817 |
| 53 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.33379341 |
| 54 | glutamate metabolic process (GO:0006536) | 4.32824175 |
| 55 | phospholipid efflux (GO:0033700) | 4.31311678 |
| 56 | positive regulation of hemostasis (GO:1900048) | 4.28064142 |
| 57 | positive regulation of blood coagulation (GO:0030194) | 4.28064142 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.25792351 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.25353678 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.25031580 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.23863042 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.23863042 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.14266443 |
| 64 | hemoglobin metabolic process (GO:0020027) | 4.13953931 |
| 65 | ketone body metabolic process (GO:1902224) | 4.07841893 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.05712830 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.03798156 |
| 68 | cholesterol efflux (GO:0033344) | 4.01218266 |
| 69 | negative regulation of blood coagulation (GO:0030195) | 4.00324684 |
| 70 | negative regulation of hemostasis (GO:1900047) | 4.00324684 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.97301346 |
| 72 | glycine metabolic process (GO:0006544) | 3.94542001 |
| 73 | regulation of apoptotic cell clearance (GO:2000425) | 3.93894988 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.92924080 |
| 75 | amine catabolic process (GO:0009310) | 3.92924080 |
| 76 | peptidyl-glutamic acid modification (GO:0018200) | 3.91712480 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 3.90720566 |
| 78 | proline metabolic process (GO:0006560) | 3.89688457 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.88807304 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.88766664 |
| 81 | porphyrin-containing compound metabolic process (GO:0006778) | 3.88384164 |
| 82 | ethanol oxidation (GO:0006069) | 3.88006934 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.86310626 |
| 84 | positive regulation of coagulation (GO:0050820) | 3.86094774 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.85960817 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.85218792 |
| 87 | drug catabolic process (GO:0042737) | 3.84526620 |
| 88 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.79178075 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 3.77450266 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.76749266 |
| 91 | cellular glucuronidation (GO:0052695) | 3.76748983 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74929371 |
| 93 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.73844423 |
| 94 | arginine metabolic process (GO:0006525) | 3.71574020 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.71204555 |
| 96 | organic acid catabolic process (GO:0016054) | 3.71204555 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 3.66885892 |
| 98 | fibrinolysis (GO:0042730) | 3.66749956 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.65237451 |
| 100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65009195 |
| 101 | fatty acid beta-oxidation (GO:0006635) | 3.63308669 |
| 102 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.61073573 |
| 103 | monocarboxylic acid catabolic process (GO:0072329) | 3.59944756 |
| 104 | 2-oxoglutarate metabolic process (GO:0006103) | 3.59354675 |
| 105 | fatty acid oxidation (GO:0019395) | 3.59123847 |
| 106 | cofactor catabolic process (GO:0051187) | 3.58871606 |
| 107 | negative regulation of coagulation (GO:0050819) | 3.58236228 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57732077 |
| 109 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.56231308 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55890549 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55890549 |
| 112 | regulation of cholesterol homeostasis (GO:2000188) | 3.54679383 |
| 113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.54317760 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.52761598 |
| 115 | lipid oxidation (GO:0034440) | 3.52470293 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.51987366 |
| 117 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.51910114 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51899271 |
| 119 | exogenous drug catabolic process (GO:0042738) | 3.50883137 |
| 120 | fatty acid catabolic process (GO:0009062) | 3.50688532 |
| 121 | cytolysis (GO:0019835) | 3.48576020 |
| 122 | aldehyde catabolic process (GO:0046185) | 3.47331569 |
| 123 | sterol homeostasis (GO:0055092) | 3.46871546 |
| 124 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.45947291 |
| 125 | complement activation, classical pathway (GO:0006958) | 3.44865434 |
| 126 | negative regulation of wound healing (GO:0061045) | 3.42101077 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 3.40754832 |
| 128 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.37575665 |
| 129 | sterol transport (GO:0015918) | 3.36560693 |
| 130 | cholesterol transport (GO:0030301) | 3.36560693 |
| 131 | acute-phase response (GO:0006953) | 3.36524311 |
| 132 | protein activation cascade (GO:0072376) | 3.35190005 |
| 133 | lipoprotein metabolic process (GO:0042157) | 3.33851234 |
| 134 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.30654614 |
| 135 | response to mercury ion (GO:0046689) | 3.28938228 |
| 136 | intestinal absorption (GO:0050892) | 3.25554266 |
| 137 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.25430788 |
| 138 | tetrapyrrole biosynthetic process (GO:0033014) | 3.25261137 |
| 139 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.24254790 |
| 140 | heme metabolic process (GO:0042168) | 3.23544723 |
| 141 | positive regulation of steroid metabolic process (GO:0045940) | 3.18905910 |
| 142 | response to methylmercury (GO:0051597) | 3.16455552 |
| 143 | oxygen transport (GO:0015671) | 3.15336622 |
| 144 | daunorubicin metabolic process (GO:0044597) | 3.12176696 |
| 145 | polyketide metabolic process (GO:0030638) | 3.12176696 |
| 146 | doxorubicin metabolic process (GO:0044598) | 3.12176696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.60152532 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.43843031 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.95793114 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.94478732 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.97569512 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95512758 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.16540734 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86479605 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.19946928 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.29555026 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00686571 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7776724 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98583003 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70102141 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67412874 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66678597 |
| 17 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.63515453 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58339397 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51543135 |
| 20 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39432227 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38961800 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37458771 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34094506 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33827538 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30835981 |
| 26 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26268783 |
| 27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23602605 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22385752 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18599738 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17383239 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13397266 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12806073 |
| 33 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.12685720 |
| 34 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.10895473 |
| 35 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.07825068 |
| 36 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04916140 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.04823732 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04779063 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03758547 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03517645 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03234688 |
| 42 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99945140 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98828073 |
| 44 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97686234 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97203783 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97140754 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94549468 |
| 48 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.91353748 |
| 49 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91254550 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90203407 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89664976 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88035679 |
| 53 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85540224 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85365529 |
| 55 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.84422551 |
| 56 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.83623320 |
| 57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82722071 |
| 58 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82391581 |
| 59 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.81790402 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80419082 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80232773 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80173875 |
| 63 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.79639778 |
| 64 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78746781 |
| 65 | ERA_21632823_ChIP-Seq_H3396_Human | 0.78156982 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77797824 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77144898 |
| 68 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.76391666 |
| 69 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.75881692 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 0.74872295 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74273531 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74164317 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74164317 |
| 74 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73480949 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73090828 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.72507537 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71620309 |
| 78 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70826606 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70649266 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69415816 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.69094767 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68624164 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68015051 |
| 84 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.67794301 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67699074 |
| 86 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67040714 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66536409 |
| 88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66321239 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.65419593 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.65214041 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.65010033 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.65010033 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63952001 |
| 94 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.63767190 |
| 95 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.63712871 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62272635 |
| 97 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.62023221 |
| 98 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.61939100 |
| 99 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.61862631 |
| 100 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.61823000 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61149961 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.61049494 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60814463 |
| 104 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.60327643 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60300099 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59921666 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.59801400 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58208325 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57509329 |
| 110 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56838259 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.56645068 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56309223 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.56155222 |
| 114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.55814249 |
| 115 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.55469711 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.54660534 |
| 117 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.54324248 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.54081546 |
| 119 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53267485 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.52706964 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52610816 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52566632 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.52426176 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52054046 |
| 125 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.51989088 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.51844023 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51812572 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51585263 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.49527482 |
| 130 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.49032413 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.48808638 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48533362 |
| 133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.48495630 |
| 134 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.48171883 |
| 135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48110625 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47926104 |
| 137 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.47804106 |
| 138 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47103774 |
| 139 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.46470218 |
| 140 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.46470218 |
| 141 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46090701 |
| 142 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.45845985 |
| 143 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45519856 |
| 144 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45424552 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45237192 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.45230037 |
| 147 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.44824844 |
| 148 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.44388429 |
| 149 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44184443 |
| 150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44099939 |
| 151 | NCOR_22424771_ChIP-Seq_293T_Human | 0.43441518 |
| 152 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.43136320 |
| 153 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42812767 |
| 154 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.42801868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.16680437 |
| 2 | MP0005360_urolithiasis | 7.24490894 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27544477 |
| 4 | MP0005365_abnormal_bile_salt | 6.08504406 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.84908712 |
| 6 | MP0003252_abnormal_bile_duct | 3.81739417 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.75314311 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.64693641 |
| 9 | MP0005083_abnormal_biliary_tract | 3.04758976 |
| 10 | MP0005410_abnormal_fertilization | 2.96953887 |
| 11 | MP0009840_abnormal_foam_cell | 2.91499861 |
| 12 | MP0005332_abnormal_amino_acid | 2.78600531 |
| 13 | MP0003122_maternal_imprinting | 2.78529386 |
| 14 | MP0003195_calcinosis | 2.73348395 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.41414173 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.25000728 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.22735502 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.10740441 |
| 19 | MP0000609_abnormal_liver_physiology | 2.09608435 |
| 20 | MP0003878_abnormal_ear_physiology | 2.05263471 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.05263471 |
| 22 | MP0000566_synostosis | 1.97615159 |
| 23 | MP0003868_abnormal_feces_composition | 1.84413429 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.82347993 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.79083220 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64781151 |
| 27 | MP0001764_abnormal_homeostasis | 1.57429969 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.49619788 |
| 29 | MP0003123_paternal_imprinting | 1.45060191 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.43805004 |
| 31 | MP0001915_intracranial_hemorrhage | 1.40163746 |
| 32 | MP0009697_abnormal_copulation | 1.39443222 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.38014966 |
| 34 | MP0003646_muscle_fatigue | 1.34201436 |
| 35 | MP0002132_abnormal_respiratory_system | 1.33877367 |
| 36 | MP0005451_abnormal_body_composition | 1.33136004 |
| 37 | MP0003698_abnormal_male_reproductive | 1.29963747 |
| 38 | MP0000604_amyloidosis | 1.28533866 |
| 39 | MP0003011_delayed_dark_adaptation | 1.27810080 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.24373837 |
| 41 | MP0004130_abnormal_muscle_cell | 1.19964537 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.18670358 |
| 43 | MP0005670_abnormal_white_adipose | 1.11843383 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.11280276 |
| 45 | MP0001929_abnormal_gametogenesis | 1.10500221 |
| 46 | MP0002822_catalepsy | 1.09873334 |
| 47 | MP0003329_amyloid_beta_deposits | 1.08645883 |
| 48 | MP0005647_abnormal_sex_gland | 1.06754236 |
| 49 | MP0005535_abnormal_body_temperature | 1.05846280 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.04689855 |
| 51 | MP0000598_abnormal_liver_morphology | 1.03536556 |
| 52 | MP0003186_abnormal_redox_activity | 1.02776922 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.00264395 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.96412377 |
| 55 | MP0002971_abnormal_brown_adipose | 0.95417291 |
| 56 | MP0002249_abnormal_larynx_morphology | 0.93155933 |
| 57 | MP0009764_decreased_sensitivity_to | 0.91201037 |
| 58 | MP0002161_abnormal_fertility/fecundity | 0.89735291 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.87842982 |
| 60 | MP0009763_increased_sensitivity_to | 0.86830142 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.86064579 |
| 62 | MP0005334_abnormal_fat_pad | 0.85549402 |
| 63 | MP0002254_reproductive_system_inflammat | 0.85261622 |
| 64 | MP0003690_abnormal_glial_cell | 0.83826485 |
| 65 | MP0000749_muscle_degeneration | 0.83225462 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 0.83158611 |
| 67 | MP0010368_abnormal_lymphatic_system | 0.83004402 |
| 68 | MP0003718_maternal_effect | 0.81241217 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.76917081 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.75219859 |
| 71 | MP0005448_abnormal_energy_balance | 0.73164596 |
| 72 | MP0008469_abnormal_protein_level | 0.70433432 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.68987915 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.68974861 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.68974861 |
| 76 | MP0008874_decreased_physiological_sensi | 0.67853754 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.67385583 |
| 78 | MP0001756_abnormal_urination | 0.66136122 |
| 79 | MP0005187_abnormal_penis_morphology | 0.65304705 |
| 80 | MP0001661_extended_life_span | 0.65062716 |
| 81 | MP0005266_abnormal_metabolism | 0.65043755 |
| 82 | MP0003121_genomic_imprinting | 0.64576703 |
| 83 | MP0004036_abnormal_muscle_relaxation | 0.61568699 |
| 84 | MP0010630_abnormal_cardiac_muscle | 0.60853689 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.60512180 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.60451706 |
| 87 | MP0008872_abnormal_physiological_respon | 0.58063412 |
| 88 | MP0003632_abnormal_nervous_system | 0.57998239 |
| 89 | MP0001529_abnormal_vocalization | 0.57226200 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.56434256 |
| 91 | MP0003953_abnormal_hormone_level | 0.55969683 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.55805270 |
| 93 | MP0003699_abnormal_female_reproductive | 0.55774760 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.55680847 |
| 95 | MP0000751_myopathy | 0.54462457 |
| 96 | MP0004087_abnormal_muscle_fiber | 0.54291320 |
| 97 | MP0003075_altered_response_to | 0.53686191 |
| 98 | MP0005408_hypopigmentation | 0.52820313 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.51498395 |
| 100 | MP0002210_abnormal_sex_determination | 0.51365625 |
| 101 | MP0008260_abnormal_autophagy | 0.50918720 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.50340976 |
| 103 | MP0004043_abnormal_pH_regulation | 0.50237472 |
| 104 | MP0000653_abnormal_sex_gland | 0.49452727 |
| 105 | MP0002928_abnormal_bile_duct | 0.48291069 |
| 106 | MP0001730_embryonic_growth_arrest | 0.47532331 |
| 107 | MP0002282_abnormal_trachea_morphology | 0.46787928 |
| 108 | MP0002106_abnormal_muscle_physiology | 0.45741922 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.45451514 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.45360332 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.43982646 |
| 112 | MP0004147_increased_porphyrin_level | 0.42694880 |
| 113 | MP0004859_abnormal_synaptic_plasticity | 0.42328388 |
| 114 | MP0009115_abnormal_fat_cell | 0.42146898 |
| 115 | MP0003633_abnormal_nervous_system | 0.41678496 |
| 116 | MP0001984_abnormal_olfaction | 0.39883717 |
| 117 | MP0002090_abnormal_vision | 0.39518188 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.39451746 |
| 119 | MP0002970_abnormal_white_adipose | 0.39202674 |
| 120 | MP0005166_decreased_susceptibility_to | 0.38259270 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.38064601 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.37949992 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.36622141 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.35218714 |
| 125 | MP0005395_other_phenotype | 0.35205485 |
| 126 | MP0009672_abnormal_birth_weight | 0.34686119 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.34169227 |
| 128 | MP0005330_cardiomyopathy | 0.33135208 |
| 129 | MP0008873_increased_physiological_sensi | 0.32677160 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.32119048 |
| 131 | MP0002269_muscular_atrophy | 0.31794149 |
| 132 | MP0003879_abnormal_hair_cell | 0.31562093 |
| 133 | MP0009053_abnormal_anal_canal | 0.31341722 |
| 134 | MP0009745_abnormal_behavioral_response | 0.31268657 |
| 135 | MP0003631_nervous_system_phenotype | 0.30194867 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.29939442 |
| 137 | MP0005452_abnormal_adipose_tissue | 0.29858079 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.29801604 |
| 139 | MP0004883_abnormal_blood_vessel | 0.29112560 |
| 140 | MP0002168_other_aberrant_phenotype | 0.29067182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.90156812 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.78027590 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.77586930 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.02192050 |
| 5 | Xanthomatosis (HP:0000991) | 6.01410733 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92521464 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.90636622 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.35661437 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.27664098 |
| 10 | Complement deficiency (HP:0004431) | 4.92004507 |
| 11 | Hyperammonemia (HP:0001987) | 4.56625763 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.54668853 |
| 13 | Osteomalacia (HP:0002749) | 4.51794079 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48540208 |
| 15 | Ketosis (HP:0001946) | 4.47009847 |
| 16 | Epidermoid cyst (HP:0200040) | 4.44045995 |
| 17 | Joint hemorrhage (HP:0005261) | 4.35394044 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16922065 |
| 19 | Hyperglycinuria (HP:0003108) | 4.14397866 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.11178558 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10234042 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 4.06528832 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.06528832 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.93808478 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.93402175 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83942949 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.83717529 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.79920848 |
| 29 | Fat malabsorption (HP:0002630) | 3.69570363 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54719665 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49574507 |
| 32 | Abnormality of complement system (HP:0005339) | 3.48083959 |
| 33 | Ketoacidosis (HP:0001993) | 3.42743095 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.42511081 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42402277 |
| 36 | Polycythemia (HP:0001901) | 3.41698124 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35109168 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.27046805 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.15082442 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.10258574 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.02094161 |
| 42 | Spontaneous abortion (HP:0005268) | 3.01457897 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.99304564 |
| 44 | Metabolic acidosis (HP:0001942) | 2.86108868 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82424385 |
| 46 | Skin nodule (HP:0200036) | 2.81212984 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.80868620 |
| 48 | Hypochromic anemia (HP:0001931) | 2.75749198 |
| 49 | Acanthocytosis (HP:0001927) | 2.75520788 |
| 50 | Gout (HP:0001997) | 2.71531401 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71271671 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.71271671 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.66095356 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.64758170 |
| 55 | Lethargy (HP:0001254) | 2.64031527 |
| 56 | Cholelithiasis (HP:0001081) | 2.64030052 |
| 57 | Steatorrhea (HP:0002570) | 2.63797268 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.61543780 |
| 59 | Cholecystitis (HP:0001082) | 2.61543780 |
| 60 | Cerebral edema (HP:0002181) | 2.56496796 |
| 61 | Myocardial infarction (HP:0001658) | 2.55972924 |
| 62 | Abnormality of reticulocytes (HP:0004312) | 2.55246914 |
| 63 | Facial shape deformation (HP:0011334) | 2.52093603 |
| 64 | Potter facies (HP:0002009) | 2.52093603 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.47568102 |
| 66 | Paralysis (HP:0003470) | 2.46335835 |
| 67 | Neonatal onset (HP:0003623) | 2.41927981 |
| 68 | Sensorimotor neuropathy (HP:0007141) | 2.35065776 |
| 69 | Vascular calcification (HP:0004934) | 2.34180511 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.33398201 |
| 71 | Toxemia of pregnancy (HP:0100603) | 2.32062243 |
| 72 | Irritability (HP:0000737) | 2.30850846 |
| 73 | Brushfield spots (HP:0001088) | 2.27034980 |
| 74 | Poikilocytosis (HP:0004447) | 2.25725632 |
| 75 | Mitral stenosis (HP:0001718) | 2.23376128 |
| 76 | Amyloidosis (HP:0011034) | 2.22332382 |
| 77 | Spastic diplegia (HP:0001264) | 2.21200370 |
| 78 | Vomiting (HP:0002013) | 2.20661237 |
| 79 | Abnormal hemoglobin (HP:0011902) | 2.20309135 |
| 80 | Broad alveolar ridges (HP:0000187) | 2.18167626 |
| 81 | Malnutrition (HP:0004395) | 2.17048373 |
| 82 | Purpura (HP:0000979) | 2.16668823 |
| 83 | Status epilepticus (HP:0002133) | 2.16626151 |
| 84 | Diaphragmatic weakness (HP:0009113) | 2.16188090 |
| 85 | Nephritis (HP:0000123) | 2.13686860 |
| 86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.11787982 |
| 87 | Abnormality of the gallbladder (HP:0005264) | 2.10988454 |
| 88 | Pancreatitis (HP:0001733) | 2.07801663 |
| 89 | Microcytic anemia (HP:0001935) | 2.07410945 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06796080 |
| 91 | Late onset (HP:0003584) | 2.06435719 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.05869348 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.05509826 |
| 94 | Glomerulonephritis (HP:0000099) | 2.04292830 |
| 95 | Hyperventilation (HP:0002883) | 2.03679570 |
| 96 | Enlarged kidneys (HP:0000105) | 2.03084382 |
| 97 | Prenatal maternal abnormality (HP:0002686) | 2.01933774 |
| 98 | Renal cortical cysts (HP:0000803) | 1.95730914 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 1.93281376 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.91492102 |
| 101 | Bifid scrotum (HP:0000048) | 1.89146587 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.88887627 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.88887627 |
| 104 | Rickets (HP:0002748) | 1.87798283 |
| 105 | Thrombophlebitis (HP:0004418) | 1.87240796 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86728168 |
| 107 | Esophageal varix (HP:0002040) | 1.86042170 |
| 108 | Increased purine levels (HP:0004368) | 1.85314527 |
| 109 | Hyperuricemia (HP:0002149) | 1.85314527 |
| 110 | Increased serum pyruvate (HP:0003542) | 1.84942664 |
| 111 | Broad palm (HP:0001169) | 1.84847454 |
| 112 | Menorrhagia (HP:0000132) | 1.84831583 |
| 113 | Gingival bleeding (HP:0000225) | 1.83654933 |
| 114 | Opisthotonus (HP:0002179) | 1.82986158 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81814468 |
| 116 | Proximal tubulopathy (HP:0000114) | 1.81513900 |
| 117 | Alkalosis (HP:0001948) | 1.80493179 |
| 118 | Reticulocytosis (HP:0001923) | 1.77325929 |
| 119 | Confusion (HP:0001289) | 1.76877407 |
| 120 | Hypertriglyceridemia (HP:0002155) | 1.76682781 |
| 121 | Abnormality of the lumbar spine (HP:0100712) | 1.76059071 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 1.75232294 |
| 123 | Acute hepatic failure (HP:0006554) | 1.74690699 |
| 124 | Widely patent fontanelles and sutures (HP:0004492) | 1.72384020 |
| 125 | Submucous cleft hard palate (HP:0000176) | 1.71597632 |
| 126 | Vaginal fistula (HP:0004320) | 1.70964119 |
| 127 | Hepatoblastoma (HP:0002884) | 1.68369413 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.68199645 |
| 129 | Glycosuria (HP:0003076) | 1.68199645 |
| 130 | Rhabdomyolysis (HP:0003201) | 1.66961939 |
| 131 | Abnormal tarsal ossification (HP:0008369) | 1.65608448 |
| 132 | Asymmetric septal hypertrophy (HP:0001670) | 1.64977540 |
| 133 | Neoplasm of the liver (HP:0002896) | 1.64415866 |
| 134 | Ileus (HP:0002595) | 1.63439720 |
| 135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.63160864 |
| 136 | Arthropathy (HP:0003040) | 1.63139750 |
| 137 | Hyperkalemia (HP:0002153) | 1.62761696 |
| 138 | Impulsivity (HP:0100710) | 1.57972095 |
| 139 | Back pain (HP:0003418) | 1.57296580 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.56505058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.16955000 |
| 2 | EIF2AK1 | 3.94650166 |
| 3 | SIK1 | 3.68564032 |
| 4 | FGFR4 | 3.32302532 |
| 5 | MAP2K4 | 3.26748731 |
| 6 | CDK12 | 3.18302766 |
| 7 | AKT3 | 3.03992008 |
| 8 | WNK1 | 2.91960164 |
| 9 | ERN1 | 2.88676561 |
| 10 | OBSCN | 2.82214531 |
| 11 | INSRR | 2.81303085 |
| 12 | DAPK2 | 2.65098085 |
| 13 | PLK4 | 2.64433979 |
| 14 | DYRK1B | 2.55122899 |
| 15 | EPHA4 | 2.53150467 |
| 16 | ERBB4 | 2.13141999 |
| 17 | TAOK3 | 2.03551856 |
| 18 | PKN2 | 1.86235266 |
| 19 | BRD4 | 1.75514067 |
| 20 | TRIB3 | 1.74331809 |
| 21 | PINK1 | 1.69412149 |
| 22 | PRPF4B | 1.60704697 |
| 23 | MAP3K4 | 1.60419630 |
| 24 | MST1R | 1.59851644 |
| 25 | PNCK | 1.54013259 |
| 26 | MAPK11 | 1.51403472 |
| 27 | DYRK3 | 1.49250118 |
| 28 | CAMK1D | 1.45240088 |
| 29 | PDK4 | 1.43675477 |
| 30 | PDK3 | 1.43675477 |
| 31 | NTRK3 | 1.41259778 |
| 32 | MAP3K7 | 1.37701303 |
| 33 | CAMK1G | 1.37683212 |
| 34 | TYRO3 | 1.25568316 |
| 35 | SGK1 | 1.23252099 |
| 36 | BRAF | 1.22948744 |
| 37 | FGFR2 | 1.17883646 |
| 38 | ABL2 | 1.17841504 |
| 39 | PRKAA2 | 1.15202443 |
| 40 | FRK | 1.14536820 |
| 41 | KSR2 | 1.13531594 |
| 42 | PIK3CG | 1.12127705 |
| 43 | DDR2 | 1.10513570 |
| 44 | STK4 | 1.09858331 |
| 45 | MAPK12 | 1.09579929 |
| 46 | TAOK2 | 1.08354822 |
| 47 | PRKCZ | 1.07794646 |
| 48 | BMX | 1.07706948 |
| 49 | FLT3 | 1.05082254 |
| 50 | SGK3 | 1.03687683 |
| 51 | JAK2 | 1.02376167 |
| 52 | CAMKK1 | 0.99956325 |
| 53 | SGK2 | 0.97229215 |
| 54 | MAP2K7 | 0.96200932 |
| 55 | PRKCG | 0.94357778 |
| 56 | PLK2 | 0.94239676 |
| 57 | PDPK1 | 0.92656453 |
| 58 | MAP3K9 | 0.91973420 |
| 59 | FGFR1 | 0.91217099 |
| 60 | PRKAA1 | 0.90335662 |
| 61 | SGK494 | 0.90154867 |
| 62 | SGK223 | 0.90154867 |
| 63 | PRKACG | 0.88829445 |
| 64 | MINK1 | 0.88278830 |
| 65 | STK38 | 0.88162053 |
| 66 | GRK6 | 0.86962875 |
| 67 | CDK7 | 0.86585568 |
| 68 | PIK3CA | 0.85821493 |
| 69 | CDK4 | 0.81923831 |
| 70 | DAPK1 | 0.81641140 |
| 71 | MTOR | 0.80778666 |
| 72 | RET | 0.80556288 |
| 73 | LATS1 | 0.80357828 |
| 74 | CAMK2G | 0.79316762 |
| 75 | RIPK1 | 0.78430586 |
| 76 | PHKG1 | 0.78089556 |
| 77 | PHKG2 | 0.78089556 |
| 78 | TTN | 0.77814938 |
| 79 | PDK1 | 0.76962469 |
| 80 | PTK6 | 0.76347842 |
| 81 | PDGFRA | 0.75704494 |
| 82 | MAP2K3 | 0.75153072 |
| 83 | MAPK4 | 0.74825747 |
| 84 | JAK1 | 0.74513283 |
| 85 | MAP2K6 | 0.74278441 |
| 86 | ERBB2 | 0.73852599 |
| 87 | MAP3K13 | 0.73252710 |
| 88 | MARK1 | 0.72360363 |
| 89 | PAK6 | 0.72283754 |
| 90 | MAP3K3 | 0.72011094 |
| 91 | TYK2 | 0.70789319 |
| 92 | NTRK1 | 0.68526960 |
| 93 | LATS2 | 0.68224958 |
| 94 | NEK9 | 0.67298371 |
| 95 | PAK3 | 0.66154284 |
| 96 | PTK2B | 0.64782667 |
| 97 | MAP3K2 | 0.63577388 |
| 98 | MAP2K1 | 0.62122287 |
| 99 | MAP3K6 | 0.61224160 |
| 100 | STK38L | 0.61128696 |
| 101 | RPS6KA1 | 0.60840019 |
| 102 | UHMK1 | 0.60723670 |
| 103 | BRSK1 | 0.59522677 |
| 104 | CAMK4 | 0.58955589 |
| 105 | KDR | 0.58791362 |
| 106 | AKT2 | 0.57621652 |
| 107 | MAP3K8 | 0.57534396 |
| 108 | PDK2 | 0.56415239 |
| 109 | RPS6KL1 | 0.56145054 |
| 110 | RPS6KC1 | 0.56145054 |
| 111 | TIE1 | 0.54592269 |
| 112 | GRK5 | 0.54486789 |
| 113 | CAMK2A | 0.53573082 |
| 114 | KSR1 | 0.53192907 |
| 115 | CSNK1E | 0.51674571 |
| 116 | CSNK1D | 0.51301203 |
| 117 | MAP3K1 | 0.50061820 |
| 118 | RPS6KA5 | 0.49771821 |
| 119 | PRKG1 | 0.49731399 |
| 120 | TESK1 | 0.49652147 |
| 121 | PIM1 | 0.49631863 |
| 122 | EEF2K | 0.49343123 |
| 123 | ICK | 0.49022679 |
| 124 | IRAK3 | 0.48460084 |
| 125 | RPS6KB1 | 0.48110477 |
| 126 | MAP3K5 | 0.47906102 |
| 127 | TAOK1 | 0.47777419 |
| 128 | PRKCQ | 0.47624204 |
| 129 | GSK3B | 0.46812814 |
| 130 | CDK2 | 0.46488902 |
| 131 | GSK3A | 0.46336885 |
| 132 | PKN1 | 0.45991295 |
| 133 | MAP3K11 | 0.45965697 |
| 134 | AKT1 | 0.44832051 |
| 135 | MAPK7 | 0.44797089 |
| 136 | WNK4 | 0.44229892 |
| 137 | CDK1 | 0.44184832 |
| 138 | PRKCH | 0.43813060 |
| 139 | SIK2 | 0.42675933 |
| 140 | MAP3K10 | 0.41633500 |
| 141 | LMTK2 | 0.40574941 |
| 142 | RPS6KA6 | 0.40372539 |
| 143 | RPS6KA3 | 0.40329085 |
| 144 | MET | 0.39924548 |
| 145 | MAPK14 | 0.39280526 |
| 146 | CSNK1G2 | 0.38259318 |
| 147 | FGFR3 | 0.38166157 |
| 148 | BRSK2 | 0.38066844 |
| 149 | CAMK1 | 0.36778853 |
| 150 | PRKCA | 0.36253669 |
| 151 | PRKACA | 0.34812686 |
| 152 | NEK1 | 0.34435106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35173514 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69066410 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46490508 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14375189 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00796122 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.81677288 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72613178 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68676950 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60436229 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54645545 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51839646 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38812449 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34919271 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.25804970 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.11750817 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07685980 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04494616 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04112069 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87176736 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79442055 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76823060 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76236953 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76228863 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69713168 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68823358 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66103782 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64524371 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60005553 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.59939327 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50583535 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50355870 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49503315 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47529241 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46827939 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41606944 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38916178 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32892774 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32647894 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32594154 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25784863 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21633493 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20887437 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19479089 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17962017 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.17787765 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14834091 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13724952 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13358082 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95158426 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94403595 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94270472 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91585337 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88129864 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86529794 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84845831 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83207207 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82745778 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82256602 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80469318 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80031516 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77834069 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75621630 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74715057 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56211379 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50475572 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47067365 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46773361 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42386605 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39890317 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39650443 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.35186992 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34672511 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34626668 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31935846 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30925648 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.30135515 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26077194 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25642026 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23561867 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22933037 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19260457 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18848450 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18832561 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17618802 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14090571 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.13406069 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08733643 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.08575719 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05813483 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.05145905 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.05108124 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03432525 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03384231 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.02612997 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.02185964 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.00256732 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1704023 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.1699990 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.1605772 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | -0.1557790 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1371969 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1321889 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1292673 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1192449 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0967756 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0954194 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0934458 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0898137 |
| 109 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0730704 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0576751 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0483598 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0359888 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0339283 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0097693 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0013513 |

